SELF ASSEMBLING ACTIVATION AGENTS TARGETED USING ACTIVE DRUG RELEASE

SELF ASSEMBLING ACTIVATION AGENTS TARGETED USING ACTIVE DRUG RELEASE

In a method for therapeutic treatment of humans and other mammals, the therapeutic composition includes a fusogenic encapsulation vesicle and an activation agent such as an organic nanotube or alpha-DL peptide enclosed in the encapsulation vesicle. The activation agent is maintained in an inactivate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: JOYCE, TIMOTHY H
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JOYCE, TIMOTHY H
description In a method for therapeutic treatment of humans and other mammals, the therapeutic composition includes a fusogenic encapsulation vesicle and an activation agent such as an organic nanotube or alpha-DL peptide enclosed in the encapsulation vesicle. The activation agent is maintained in an inactivated form and becomes activated by an activation condition. Dans une méthode de traitement thérapeutique d'êtres humains ou d'autres mammifères, une composition thérapeutique contient une vésicule d'encapsulation fusogénique et un agent d'activation, tel qu'un nanotube organique ou un peptide alpha -DL compris dans la vésicule d'encapsulation. Ledit agent d'activation est maintenu sous une forme inactivée et est activé par une condition d'activation.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2005094265A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2005094265A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2005094265A23</originalsourceid><addsrcrecordid>eNrjZHAJdvVxU3AMDnb1dfLx9HNXcHQO8QxzDPH091NwdHf1CwlWCHEMcncNcXVRCA2GK3BVcAkKdVcIcvVxdQx25WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgYGpgaWJkZmpo5GxsSpAgADxSyn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SELF ASSEMBLING ACTIVATION AGENTS TARGETED USING ACTIVE DRUG RELEASE</title><source>esp@cenet</source><creator>JOYCE, TIMOTHY H</creator><creatorcontrib>JOYCE, TIMOTHY H</creatorcontrib><description>In a method for therapeutic treatment of humans and other mammals, the therapeutic composition includes a fusogenic encapsulation vesicle and an activation agent such as an organic nanotube or alpha-DL peptide enclosed in the encapsulation vesicle. The activation agent is maintained in an inactivated form and becomes activated by an activation condition. Dans une méthode de traitement thérapeutique d'êtres humains ou d'autres mammifères, une composition thérapeutique contient une vésicule d'encapsulation fusogénique et un agent d'activation, tel qu'un nanotube organique ou un peptide alpha -DL compris dans la vésicule d'encapsulation. Ledit agent d'activation est maintenu sous une forme inactivée et est activé par une condition d'activation.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20051013&amp;DB=EPODOC&amp;CC=WO&amp;NR=2005094265A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20051013&amp;DB=EPODOC&amp;CC=WO&amp;NR=2005094265A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JOYCE, TIMOTHY H</creatorcontrib><title>SELF ASSEMBLING ACTIVATION AGENTS TARGETED USING ACTIVE DRUG RELEASE</title><description>In a method for therapeutic treatment of humans and other mammals, the therapeutic composition includes a fusogenic encapsulation vesicle and an activation agent such as an organic nanotube or alpha-DL peptide enclosed in the encapsulation vesicle. The activation agent is maintained in an inactivated form and becomes activated by an activation condition. Dans une méthode de traitement thérapeutique d'êtres humains ou d'autres mammifères, une composition thérapeutique contient une vésicule d'encapsulation fusogénique et un agent d'activation, tel qu'un nanotube organique ou un peptide alpha -DL compris dans la vésicule d'encapsulation. Ledit agent d'activation est maintenu sous une forme inactivée et est activé par une condition d'activation.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAJdvVxU3AMDnb1dfLx9HNXcHQO8QxzDPH091NwdHf1CwlWCHEMcncNcXVRCA2GK3BVcAkKdVcIcvVxdQx25WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgYGpgaWJkZmpo5GxsSpAgADxSyn</recordid><startdate>20051013</startdate><enddate>20051013</enddate><creator>JOYCE, TIMOTHY H</creator><scope>EVB</scope></search><sort><creationdate>20051013</creationdate><title>SELF ASSEMBLING ACTIVATION AGENTS TARGETED USING ACTIVE DRUG RELEASE</title><author>JOYCE, TIMOTHY H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2005094265A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2005</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>JOYCE, TIMOTHY H</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JOYCE, TIMOTHY H</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SELF ASSEMBLING ACTIVATION AGENTS TARGETED USING ACTIVE DRUG RELEASE</title><date>2005-10-13</date><risdate>2005</risdate><abstract>In a method for therapeutic treatment of humans and other mammals, the therapeutic composition includes a fusogenic encapsulation vesicle and an activation agent such as an organic nanotube or alpha-DL peptide enclosed in the encapsulation vesicle. The activation agent is maintained in an inactivated form and becomes activated by an activation condition. Dans une méthode de traitement thérapeutique d'êtres humains ou d'autres mammifères, une composition thérapeutique contient une vésicule d'encapsulation fusogénique et un agent d'activation, tel qu'un nanotube organique ou un peptide alpha -DL compris dans la vésicule d'encapsulation. Ledit agent d'activation est maintenu sous une forme inactivée et est activé par une condition d'activation.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2005094265A2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title SELF ASSEMBLING ACTIVATION AGENTS TARGETED USING ACTIVE DRUG RELEASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A10%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JOYCE,%20TIMOTHY%20H&rft.date=2005-10-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2005094265A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true